検索結果

ntagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as an eye ...

Overseas Activities | SENJU Pharmaceutical

h and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the er...

Overseas Activities | SENJU Pharmaceutical

h and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the er...

Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical

We will contribute to medical care and your health requirements in the new era through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fiel...

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

From eye drops to contact lens preparations-Mytear eye solutions head a diverse line of trusted products Building on a reputation for excellence in ophthalmological drugs, Senju Pharmaceutical has cul...